Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Sonnet Biotherapeutics Holdings Inc (SONN)

Sonnet Biotherapeutics Holdings Inc (SONN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Sonnet Biotherapeutics Holdings Inc 100 OVERLOOK CENTER SUITE 102 PRINCETON NJ 08540 USA

www.sonnetbio.com P: 609-375-2227

Description:

Sonnet BioTherapeutics Holdings Inc. is an oncology-focused biotechnology company with a proprietary platform for biologic drugs of single or bispecific action. Sonnet BioTherapeutics Holdings Inc., formerly known as Chanticleer Holdings Inc., is based in PRINCETON, N.J.

Key Statistics

Overview:

Market Capitalization, $K 5,709
Enterprise Value, $K 3,439
Shares Outstanding, K 3,069
Annual Sales, $ 150 K
Annual Net Income, $ -18,830 K
Last Quarter Sales, $ 20 K
Last Quarter Net Income, $ -1,170 K
EBIT, $ -14,460 K
EBITDA, $ -14,380 K
60-Month Beta 0.62
% of Insider Shareholders 2.00%
% of Institutional Shareholders 9.45%
Float, K 3,008
% Float 98.00%
Short Volume Ratio 0.69

Growth:

1-Year Return -63.45%
3-Year Return -99.63%
5-Year Return -99.98%
5-Year Revenue Growth -99.63%
5-Year Earnings Growth 99.84%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.31 on 02/14/24
Latest Earnings Date 05/08/24 [--]
Earnings Per Share ttm -10.64
EPS Growth vs. Prev Year 98.24%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-22 on 09/01/23

SONN Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -519.54%
Return-on-Assets % -169.55%
Profit Margin % -12,553.33%
Debt/Equity 0.00
Price/Sales 36.71
Price/Cash Flow N/A
Price/Book 2.11
Book Value/Share 0.84
Interest Coverage -1.64
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar